SEC Form 4 · accession 0001437749-17-014749
PLx Pharma Inc. · PLXP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Natasha Giordano
Officer — CEO · Director
Period of report
Aug 11, 2017
Accepted (ET)
Aug 14, 2017 · 5:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001497504
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $6.72 | Aug 11, 2017 | A | 86,872 | A | Aug 11, 2017 | Aug 11, 2027 | Common Stock | 86,872 | 86,872 | D |